Get the Stockscreener App
28.88
0.59%
0.2143
Assembly Biosciences Inc stock is traded at $28.88, with a volume of 11,492.
It is up +0.59% in the last 24 hours and down -2.53% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$28.67
Open:
$28.65
24h Volume:
11,492
Relative Volume:
0.11
Market Cap:
$452.79M
Revenue:
$72.30M
Net Income/Loss:
$-6.12M
P/E Ratio:
-15.71
EPS:
-1.8384
Net Cash Flow:
$-41.16M
1W Performance:
+4.83%
1M Performance:
-2.53%
6M Performance:
+16.90%
1Y Performance:
+166.79%
1-Day Range:
$28.54
$29.53
1-Week Range:
$27.50
$30.18
52-Week Range:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
28.54 | 454.78M | 72.30M | -6.12M | -41.16M | -1.8384 |
VRTX
Vertex Pharmaceuticals Inc
|
455.43 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.21 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
331.19 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.53 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.68 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-18-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
Analyst Patrick R. Trucchio Reiterates Buy Rating for ASMB | ASM - GuruFocus
Highs Report: Is Assembly Biosciences Inc being accumulated by smart moneyOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial - TipRanks
The Technical Signals Behind (ASMB) That Institutions Follow - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen - MarketBeat
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives - simplywall.st
Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB) - Seeking Alpha
Assembly Biosciences, Inc. 2025 Annual Report – Pipeline, Risk Factors, and Financial Outlook - Minichart
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS - MarketBeat
Assembly Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Assembly Biosciences Q4 Earnings: Profit Announced, Annual Loss NarrowsNews and Statistics - IndexBox
Assembly Biosciences (ASMB) launches $100M ATM via Jefferies under $400M shelf - Stock Titan
Assembly Biosciences: Fourth Quarter Financial Results Overview - Bitget
Assembly Biosciences: Q4 Earnings Snapshot - marketscreener.com
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights - The Manila Times
Assembly Biosciences 2025 net loss narrows - TradingView
Assembly Biosciences (NASDAQ: ASMB) advances antiviral pipeline and expands Gilead deal - Stock Titan
ASMB: 2025 revenue jumped to $72.3M, net loss shrank to $6.1M, and cash reserves rose to $248.1M - TradingView
Assembly Biosciences (Nasdaq: ASMB) slashes 2025 loss as Gilead deal lifts revenue - Stock Titan
Gilead deal hands Assembly Bio $35M as herpes program advances - Stock Titan
Panic Selling: Is Assembly Biosciences Inc being accumulated by smart money2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Risk Analysis: Can Assembly Biosciences Inc stock double in the next yearQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assembly Biosciences Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Farallon Capital Management LLC Takes $31.43 Million Position in Assembly Biosciences, Inc. $ASMB - MarketBeat
Commodore Capital LP Purchases Shares of 1,000,000 Assembly Biosciences, Inc. $ASMB - MarketBeat
Assembly Biosciences (ASMB) Projected to Post Earnings on Thursday - MarketBeat
Precision Trading with Assembly Biosciences Inc. (ASMB) Risk Zones - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Stock Report: Is Tecnoglass Inc forming a bullish divergenceWeekly Gains Report & Safe Entry Point Identification - baoquankhu1.vn
Published on: 2026-03-10 01:27:50 - baoquankhu1.vn
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes - MSN
ASMB Earnings History & Surprises | EPS & Revenue Results | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Assembly Biosciences identifies new compounds for HSV infection - bioworld.com
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
Patient Square Capital LP Invests $3.46 Million in Assembly Biosciences, Inc. $ASMB - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Will Assembly Biosciences Inc. stock benefit from infrastructure spendingWeekly Investment Recap & Safe Swing Trade Setup Alerts - mfd.ru
What is the target price for Assembly Biosciences Inc. stockQuarterly Market Review & AI Powered Buy and Sell Recommendations - mfd.ru
Trading the Move, Not the Narrative: (ASMB) Edition - Stock Traders Daily
Take Profit: Is Assembly Biosciences Inc stock trending bullishMarket Risk Report & Safe Capital Growth Plans - baoquankhu1.vn
Is Assembly Biosciences Inc. benefiting from innovation trendsLayoff News & Safe Entry Point Identification - mfd.ru
ASMB PE Ratio & Valuation, Is ASMB Overvalued - Intellectia AI
What is Assembly Biosciences Inc. s 5 year growth outlookJuly 2025 PostEarnings & Low Risk High Reward Ideas - mfd.ru
Bearish Setup: Can Assembly Biosciences Inc stock double in the next yearJuly 2025 Gainers & Real-Time Buy Signal Notifications - baoquankhu1.vn
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.99%
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):